🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Weiser

Tel Aviv University

ORCID: 0000-0003-3638-0271

Also affiliated with Sheba Medical Center

MedicinePsychologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.390Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample

Schizophrenia(2025)10.1038/s41537-025-00598-x
Top 47%
0.390DataRank
Top 47%8 citations

Sandra Vieira, Dominic Oliver, Alexis E. Cullen, Matthew J. Kempton, Paolo Fusar‐Poli +86 more

Papers

Driven by 7 papers — median percentile 53. Top paper: “Biological insights from 108 schizophrenia-associated genetic loci”.

Biological insights from 108 schizophrenia-associated genetic loci

Nature(2014)10.1038/nature13595
N/A
1.3DataRank · unranked
8042 citations

Stephan Ripke, Aiden Corvin, Jesse R. Dixon, Kai-How Farh, Peter Holmans +284 more

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

Nature Genetics(2016)10.1038/ng.3725
N/A
1.1DataRank · unranked
1129 citations

Daniel P. Howrigan, Daniele Merico, Bhooma Thiruvahindrapuram, Wenting Wu, Douglas S. Greer +267 more

Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial

American Journal of Psychiatry(2023)10.1176/appi.ajp.20220533
N/A
0.653DataRank · unranked
19 citations

Omer Azriel, Daniel S. Pine, Amit Lazarov, Omer Sol, Mark Weiser +4 more

Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies

Translational Psychiatry(2023)10.1038/s41398-023-02661-6
N/A
0.500DataRank · unranked
27 citations

Pierre Berthert, Andrew J. Lawrence, Seyed Mostafa Kia, Celso Arango, Richard Dinga +13 more

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample

Schizophrenia(2025)10.1038/s41537-025-00598-x
Top 47%
0.390DataRank
Top 47%8 citations

Sandra Vieira, Dominic Oliver, Alexis E. Cullen, Matthew J. Kempton, Paolo Fusar‐Poli +86 more

Neural activation changes following attention bias modification treatment or a selective serotonin reuptake inhibitor for social anxiety disorder

Psychological Medicine(2024)10.1017/s0033291724001521
N/A
0.255DataRank · unranked
4 citations

Gal Arad, Niv Tik, Mark Weiser, Miki Bloch, Eddie Garber +5 more

Misreporting of Results of Research in Psychiatry

Schizophrenia Bulletin(2021)10.1093/schbul/sbab040
N/A
0DataRank · unranked
8 citations

Linda Levi, Ortal Livnah, Joseph S. Ross, Michael B. Knable, Michael Davidson +3 more